Effects of hyperglycemia on the angiotensin II receptor type 1 expression and insulin secretion in an INS-1E pancreatic beta-cell line

Journal of the Pancreas

Volumn 9, Issue 3, 2008, Pages 290-299

  Leung, Kwan Keung ^a   Leung, Po Sing ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Diabetes mellitus; Hyperglycemia; Insulin; Oxidative stress; Receptor, angiotensin, type 1

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; BETA ACTIN; INSULIN; NITROBLUE TETRAZOLIUM; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ANIMAL CELL; ARTICLE; CELL LINE; CELL MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DIABETES MELLITUS; GENE EXPRESSION; HYPERGLYCEMIA; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; INSULIN RELEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RECEPTOR OCCUPANCY; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; HYPERGLYCEMIA; INSULIN; INSULIN-SECRETING CELLS; OXIDATIVE STRESS; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RNA, MESSENGER; TISSUE DISTRIBUTION;

EID: 45749135926     PISSN: None     EISSN: 15908577     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Wong KC, Wang Z. Prevalence of type 2 diabetes mellitus of Chinese populations in Mainland China, Hong Kong, and, Taiwan. Diabetes Res Clin Pract 2006; 73:126-34.
2. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, et al. Prevalence of diabetes, impaired fasting glucose, and impaired gluccose-tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey. Diabetes Care 1998; 21:518-24.
3. Borrows NR, Geiss LS, Engelgau MM, Acton KJ. Prevalence of diabetes among Native Americans and Alaska Natives, 1990-1997. an increasing burden. Diabetes Care 2000; 23:1786-90.
4. Pinhas-Hamiel, O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeitler P. Increased incidence of non-insulin dependent diabetes mellitus among adolescents. J Pediatr 1996; 128:608-15.
5. Scheen AJ. Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. Meta-analysis of randomised clinical trials. Diabetes Metab 2004; 30:487-96.
6. Leung PS. The physiology of a local renin-angiotensin system in the pancreas. J Physiol 2007; 580:31-7.
7. Lau T, Carlsson PO, Leung PS. Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets. Diabetologia 2004; 47:240-8.
8. Wang Z, Rao PJ, Shillcutt SD, Newman WH. Angiotensin II induces proliferation of human cerebral artery smooth muscle cells through a basic fibroblast growth factor (bFGF) dependent mechanism. Neurosci Lett 2005; 373:38-41.
9. Papp M, Li X, Zhuang J, Wang R, Uhal BD. Angiotensin receptor subtype AT(1) mediates alveolar epithelial cell apoptosis in response to ANG II. Am J Physiol Lung Cell Mol Physiol 2002; 282:L713-8.
10. Zhou Y, Chen Y, Dirksen WP, Morris M, Periasamy M. AT1b receptor predominantly mediates contractions in major mouse blood vessels. Circ Res 2003; 93:1089-94.
11. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996; 97:1916-23.
12. Chu KY, Lau T, Carlsson PO, Leung PS. Angiotensin II type 1 receptor blockade improves beta-cell function and glucose tolerance in a mouse model of type 2 diabetes. Diabetes 2006; 55:367-74.
13. Chan YC, Leung PS. Angiotensin II type 1 receptor-dependent nuclear factor-kappaB activation-mediated proinflammatory actions in a rat model of obstructive acute pancreatitis. J Pharmacol Exp Ther 2007; 323:10-8.
14. Lupi R, Del Guerra S, Bugliani M, Boggi U, Mosca F, Tord S, et al. The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets. Eur J Endocrinol 2006; 154:355-61.
15. Bas M, Hoffmann TK, Kojda G, Bier H. ACE-inhibitor induced angiodema. Laryngorhinootologie 2007; 86:804-8.
16. Sica DA, Gehr TW, Ghosh S. Clinical pharmacokinetics of losartan. Clin Pharmacokinet 2005; 44:797-814.
17. Lim SC, Koh AF, Goh SK, Chua CL, Heng BL, Subramaniam T, Sum CF. Angiotensin receptor antagonist vs. angiotensin-converting enzyme inhibitor in Asian subjects with type 2 diabetes and albuminuria - a randomized crossover study. Diabetes Obes Metab 2007; 9:477-82.
18. Carlsson PO, Berne C, Janssen L. Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats. Diabetologia 1998; 41:127-33.
19. Ramracheya RD, Muller DS, Wu Y, Whitehouse BJ, Huang GC, Amiel SA, et al. Direct regulation of insulin secretion by angiotensin II in human islets of Langerhans. Diabetologia 2006; 49:321-31.
20. Chu KY, Leung PS. Angiotensin II Type 1 receptor antagonism mediates uncoupling protein 2-driven oxidative stress and ameliorates pancreatic islet beta-cell function in young Type 2 diabetic mice. Antioxid Fedox Signal 2007; 9:869-78.
21. Nakayama M. Inoguchi T, Sonta T, Maeda Y, Sasaki S, Sawada F, et al. Increased expression of NAD(P)H oxidase in islets of animal models of Type 2 diabetes and its improvement by an AT1 receptor antagonist. Biochem Biophys Res Commun 2005; 332:927-33.
22. Zhang CY. Baffy G, Perret P, Krauss S, Peroni O, Grujic D, et al. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 2001; 105:745-55.
23. Chan CB, MacDonald PE, Saleh MC, Johns DC, Marbàn E, Wheeler MP. Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets. Diabetes 1999; 48:1482-6.
24. Briaud I, Kelpe CL, Johnson LM, Tran PO, Poitout V. Differential effects of hyperlipidemia on insulin secretion in islets of langerhans from hyperglycemic versus nomoglycemic rats. Diabetes 2002; 51:662-8.
25. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 2002; 23:599-622.
26. Janiak P, Bidcuard JP, Cadrouvele C, Poirier B, Gouraud L, Gratalcup Y, et al. Long-term blockade of angiotensin AT1 receptors increases survival of obese Zucker rats. Eur J Pharmacol 2006; 534:271-9.